There was a significant amount of unusual options action this past week in Pfizer, and one trade stuck out in particular…
Upgrades and Downgrades for Monday, 8/2
by •
Here are today’s upgrades and downgrades: Daimler AG, Square, Volkswagen, First Solar, Bloomin’ Brands, Grainger, Estee Lauder, Teladoc and more.
25 Stocks to Watch Next Week (Earnings!)
by •
A number of notable stocks report earnings next week. Here are the ones we’re watching: Alibaba, Amgen, Draftkings, Moderna and more.
This Stock Just Broke Out: 25%-177% Potential Return
by •
Buy above $9.60 for a target of $12-$15 in the next 4-6 months.
Trade This Stock for a Potential 100% Return in 7 Weeks
by •
It has strong fundamentals and looks like it may have put in a double-bottom in the last few weeks.
High-Risk / High-Reward Trade: Buy This Stock Above $4.90 per Share (43%-178% Potential Upside)
by •
It has multiple catalysts and bullish indications on its chart.
Upgrades and Downgrades for Friday, 7/30
by •
Here are today’s upgrades and downgrades: BASF, Nokia, T-Mobile, Hartford Financial, Adecco, Rio Tinto, Pinterest and more.
This Quick Fiserv (NASDAQ: FISV) Trade Could Double Your Money
by •
The thing that got my attention last night with the underlying stock was that the 10-day moving average just made a bullish crossover of the 50-day. We see the same thing happened in mid-February and then the stock rallied all the way up above $126. I’m looking for a similar outcome over the next five to six weeks and think the $125 range is easily within reach, which would more than double the value of our call option.
Trader Just Bet $2.5 Million This Popular Stock Will Drop 50% in 17 Months!
by •
It’s one of five of the most interesting “smart money” trades we came across in the past week.
Shaquille O’Neal is Now This Stock’s Largest Shareholder (Buy it Above $1.90 per share)
by •
If you want to join Shaq, the ideal buy level is above $1.90 per share. Our target prices are $2.60 and $4.30, which would offer 27%-126% potential upside.